{"schema_version":"secwatch.filing_event.v1","accession":"0001639691-23-000108","form_type":"8-K","ticker":"LIVN","cik":"0001639691","company_name":"LivaNova PLC","filed_at":"2023-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.903613+00:00","generated_at":"2026-06-09T02:45:13.626494+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"LivaNova Q3 revenue $286M (+13.3% YoY); raises full-year guidance","bullets":["Revenue $286.1M, up 13.3% reported and 12.1% constant currency vs prior year.","GAAP diluted loss per share $0.14; adjusted diluted EPS $0.73.","Received FDA 510(k) clearance and CE Mark for Essenz In-Line Blood Monitor.","Raised full-year 2023 revenue and adjusted diluted EPS guidance.","Double-digit revenue growth across all regions and three business units."],"urls":{"canonical":"https://secwatch.observer/filing/0001639691-23-000108","json":"https://secwatch.observer/filing/0001639691-23-000108.json","markdown":"https://secwatch.observer/filing/0001639691-23-000108.md","text":"https://secwatch.observer/filing/0001639691-23-000108.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1639691/000163969123000108/0001639691-23-000108-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1639691/000163969123000108/livn-20231101.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T02:45:13.626494+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"eb442b3449122f12ac5ff8b7a66f91dbf3c185a4","claim":"LivaNova PLC reported the quarter ended September 30, 2023 results: revenue $286.1 million, EPS $0.73. Guidance raised.","evidence_excerpt":"Third-quarter revenue of $286.1 million increased 13.3% on a reported basis and increased 12.1% on a constant-currency basis, as compared to the prior-year period","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1639691/000163969123000108/0001639691-23-000108-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2023"},{"label":"Revenue","value":"$286.1 million"},{"label":"EPS","value":"$0.73"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}